Back to results
US 2015/0148415 A1Published application
Derivatized dendrimer with low citotoxicity for in vivo, ex vivo, in vitro or in situ chelation of heavy metals or actinides
OwnerLeonardo SILVA SANTOS, Rainer FISCHER +2inventors
InventorsLeonardo SILVA SANTOS, Rainer FISCHER, Luis GUZMAN, Fabiane M. NACHTIGALL
Life of this patent
Estimating the term…
Abstract
The present invention considers derivatized nanomolecules with proven effectiveness to bind to actinides, more specifically uranium, during in vivo, ex vivo, in vitro or in situ assays. When assayed in vivo, the invention showed a reduction in at least kidney damage due to exposition to uranium.
Claims11
Derivatized dendrimer with low citotoxicity for in vivo, ex vivo, in vitro or in situ chelation of heavy metals or actinides, comprising a polyamidoamine (PAMAM) dendrimers derivatized with an amino acid and a terminal functional group.
Dependencies are inferred from the claim text.